TY-306

N/A

Report date: 2022/01/05 15:24:33

NME

Base Information

Drug NameTY-306

Drug Alias NameTY-306

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCyclin-dependent kinase 6 inhibitorsCyclin-dependent kinase 4 inhibitors

TargetsCyclin-dependent kinase 6Cyclin-dependent kinase 4

Therapy Area/IndicationsOvarian NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesTYK Medicines Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsOvarian NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

ATC CodeN/A